Sheela Foam Ltd Q3 FY2024 Concall Summary

Source transcript PDF: https://www.stockscans.in/document/4e6nwtpfq3ihqlxoba9rg53f.pdf

Key Takeaways


Kurlon Integration & Margin Recovery

Rahul Gautam: "I would say that the first job was to really get it to the normative levels and normal levels of about a INR1,000 crores and at about a 10% EBITDA. And I think on a run rate basis, we may have come very close to it already."

Stand-alone Performance & Marketing Investment

Rahul Gautam: "we are consolidating all the other small little brand here and there, which may have been additional or a part of the industrial side or the furniture side and focusing on Sleepwell and the percentage of Sleepwell in the business is on the increase, and that will keep on increasing."

Furlenco: Path to Profitability


Tarang: Cotton-to-Foam Conversion Play

Nilesh Mazumdar: "Tarang is positioned the customer who is currently using a cotton mattress. A cotton mattress in this country today cost anywhere between INR800 to INR1,200 for a mattress. So that's the customer segment to whom we are taking. Tarang is light set at around INR2,000 with a 3-year warranty on it."

International Business: Mixed Conditions


Guidance & Commitments

CommitmentSpecificsTimeline
Kurlon margin normalizationNormalized EBITDA margin of 7%-8% visible in reported numbers"Another quarter for stabilizing"
Kurlon EBITDA targetReach 10% EBITDA on ~₹1,000 crores revenueRun rate already close; "not seeing too much time"
Stand-alone EBITDA marginNormalize to ~12.5% from current 10.5%Once marketing spend stabilizes to 6%-6.5% next financial year
Furlenco PBT profitabilityPBT positiveFebruary 2024
Europe volumesVolume increaseBy end of current quarter (Jan-Mar)
Australia volumesVolume increase from new capacityCurrent quarter
ROE target18-20% on new equity base of ₹2,900 crores"A couple of years down the line"

Key Metrics

MetricQ3 FY24
Consolidated revenue₹879 cr, +15.5% YoY and +43.3% QoQ
Consolidated EBITDA₹76 cr, +0.8% YoY and +15% QoQ
Consolidated EBITDA margin8.67%
Consolidated net profit₹31 cr, -49% YoY
Standalone EBITDA margin10.5%
Standalone contribution margin improvement+4.7% YoY and +1.1% QoQ
Marketing expenses as a percentage of revenue8.6%, up from 5.4% QoQ
Expected marketing expense stabilization (next financial year)6% to 6.5%
Normalized standalone EBITDA margin expectation~12.5%
Sleepwell brand mattress segment growth26% YoY
Kurlon annualized revenue (based on 72 days post-acquisition)~₹890 cr
Kurlon reported EBITDA margin3.6%
Kurlon normalized EBITDA margin (excl. one-off selling and promotional expenses)7% to 8%
Kurlon sale expenses as a percentage of revenue20.1%
Mattress volumes (combined Kurlon and Sheela Foam)~634,000 units
Net worth post-QIP₹2,900 cr
US anti-dumping duty on mattress exports from India27% to 30%
Europe topline reduction10% to 12%, due to raw material price decline